Specifically, the researchers found that two grape derived compounds dihydrocaffeic acid (DHCA) and malvidin-3'-O-glucoside (Mal-gluc) can promote resilience in mouse models of depression by modulating inflammation and synaptic plasticity, respectively. “Our research shows that combination treatment with the two compounds can promote resilience against stress-mediated depression-like phenotypes by modulating systemic inflammatory responses and brain synaptic plasticity in a mouse model of depression,” said Jun Wang, Associate Professor at Icahn School of Medicine at Mount Sinai.
Source: thehealthsite